Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026 18:00:00
Paxman Rg (Stockholm)
Závěr k 13.2.2026 Změna (%) Změna (SEK) Objem obchodů (SEK)
49,00 3,16 1,50 736 848
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.02.2026
Popis společnosti
Obecné informace
Název společnostiPaxman AB (publ)
TickerPAX
Kmenové akcie:Ordinary Shares
RICPAX.ST
ISINSE0009806284
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 30.09.2025 142
Akcie v oběhu k 30.09.2025 23 273 416
MěnaSEK
Kontaktní informace
UlicePirgatan 13
MěstoKARLSHAMN
PSČ374 35
ZeměSweden
Kontatní osobaEmelie Gustafsson
Funkce kontaktní osobyChief Financial Officer
Telefon46 704 543 791
Kontatní telefon46 704 543 791

Business Summary: Paxman AB (publ) is a Sweden-based developer of scalp cooling technology. The cooling system aims to reduce the risk of hair loss connected with cytostatic treatment of cancer. The Company offers a stand-alone, mobile electric cooling unit, which markets under the name Paxman Scalp Cooler, which is a liquid-based cooling system that cools down the patients scalp through the silicone hat. The product has two versions - for one or two patients to be cooled at once. Each device contains a built-in touch screen with a menu-controlled graphic user interface to monitor the process. The lightweight system enables patient to participate in other activities. The Company’s primary markets are Great Britain, Scandinavian countries, the Netherlands, Belgium and Australia.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Paxman AB (publ) revenues increased 23% to SEK228.9M. Net loss applicable to common stockholders totaled SEK7.4M vs. income of SEK27.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects Other operating costs increase from SEK28.2M to SEK56.7M (expense), Personnel costs increase of 48% to SEK72.8M (expense).
Odvětvová klasifikace
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICS2007Surgical & Medical Instrument Mfg
NAICS1997Surgical and Medical Instrument Manufacturing
SICSurgical And Medical Instruments



  • Poslední aktualizace: 14.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, DirectorRichard Paxman4210.02.201710.02.2017
Chief Financial OfficerEmelie Gustafsson4501.03.2020